Jasemine C. Chambers

Array ( [id] => 3691150 [patent_doc_number] => 05650148 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system' [patent_app_type] => 1 [patent_app_number] => 8/209609 [patent_app_country] => US [patent_app_date] => 1994-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 134 [patent_no_of_words] => 42037 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650148.pdf [firstpage_image] =>[orig_patent_app_number] => 209609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3580942 [patent_doc_number] => 05580776 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Modified hepatocytes and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/201721 [patent_app_country] => US [patent_app_date] => 1994-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 31 [patent_no_of_words] => 17550 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580776.pdf [firstpage_image] =>[orig_patent_app_number] => 201721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685370 [patent_doc_number] => 05633426 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'In vivo use of human bone marrow for investigation and production' [patent_app_type] => 1 [patent_app_number] => 8/194717 [patent_app_country] => US [patent_app_date] => 1994-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7305 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633426.pdf [firstpage_image] =>[orig_patent_app_number] => 194717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3485633 [patent_doc_number] => 05470560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'Method for evaluating immunogenicity' [patent_app_type] => 1 [patent_app_number] => 8/192316 [patent_app_country] => US [patent_app_date] => 1994-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7552 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470560.pdf [firstpage_image] =>[orig_patent_app_number] => 192316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3611329 [patent_doc_number] => 05565362 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'DNA sequences to target proteins to the mammary gland for efficient secretion' [patent_app_type] => 1 [patent_app_number] => 8/185574 [patent_app_country] => US [patent_app_date] => 1994-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 7949 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565362.pdf [firstpage_image] =>[orig_patent_app_number] => 185574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619456 [patent_doc_number] => 05612018 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Drug screening and treatment for HIV thymocyte depletion' [patent_app_type] => 1 [patent_app_number] => 8/183178 [patent_app_country] => US [patent_app_date] => 1994-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4853 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612018.pdf [firstpage_image] =>[orig_patent_app_number] => 183178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3564402 [patent_doc_number] => 05482847 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-09 [patent_title] => 'Esterase genes, esterase, recombinant plasmids and transformants containing the recombinant plasmid and methods of producing optically active carboxylic acids and their enantiomeric esters using said trasnformants' [patent_app_type] => 1 [patent_app_number] => 8/183213 [patent_app_country] => US [patent_app_date] => 1994-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 5529 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/482/05482847.pdf [firstpage_image] =>[orig_patent_app_number] => 183213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3649945 [patent_doc_number] => 05629414 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Diagnostic genes for toxoplasmosis' [patent_app_type] => 1 [patent_app_number] => 8/182673 [patent_app_country] => US [patent_app_date] => 1994-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5975 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629414.pdf [firstpage_image] =>[orig_patent_app_number] => 182673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3486858 [patent_doc_number] => 05474930 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-12 [patent_title] => 'Non-tumorigenic cell lines for expression of genes' [patent_app_type] => 1 [patent_app_number] => 8/177637 [patent_app_country] => US [patent_app_date] => 1994-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4895 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/474/05474930.pdf [firstpage_image] =>[orig_patent_app_number] => 177637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3556032 [patent_doc_number] => 05574205 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => 'Homologous recombination for universal donor cells and chimeric mammalian hosts' [patent_app_type] => 1 [patent_app_number] => 8/175469 [patent_app_country] => US [patent_app_date] => 1993-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 10 [patent_no_of_words] => 19691 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/574/05574205.pdf [firstpage_image] =>[orig_patent_app_number] => 175469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3582677 [patent_doc_number] => 05491284 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-13 [patent_title] => 'Nude mouse model for neoplastic disease' [patent_app_type] => 1 [patent_app_number] => 8/169735 [patent_app_country] => US [patent_app_date] => 1993-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5505 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/491/05491284.pdf [firstpage_image] =>[orig_patent_app_number] => 169735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622571 [patent_doc_number] => 05614620 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'DNA binding proteins including androgen receptor' [patent_app_type] => 1 [patent_app_number] => 8/149691 [patent_app_country] => US [patent_app_date] => 1993-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 12034 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614620.pdf [firstpage_image] =>[orig_patent_app_number] => 149691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3543406 [patent_doc_number] => 05554528 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-10 [patent_title] => 'Compositions and methods for inhibition of HIV production' [patent_app_type] => 1 [patent_app_number] => 8/147829 [patent_app_country] => US [patent_app_date] => 1993-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17799 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/554/05554528.pdf [firstpage_image] =>[orig_patent_app_number] => 147829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3475654 [patent_doc_number] => 05432076 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-11 [patent_title] => 'Alteration of the interaction of a T-cell receptor with a protein-tyrosine kinase' [patent_app_type] => 1 [patent_app_number] => 8/131206 [patent_app_country] => US [patent_app_date] => 1993-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5458 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/432/05432076.pdf [firstpage_image] =>[orig_patent_app_number] => 131206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3408322 [patent_doc_number] => 05411732 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-02 [patent_title] => 'Preparation of fused proteins, antibodies and processes therefore' [patent_app_type] => 1 [patent_app_number] => 8/130430 [patent_app_country] => US [patent_app_date] => 1993-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 6707 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/411/05411732.pdf [firstpage_image] =>[orig_patent_app_number] => 130430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3610440 [patent_doc_number] => 05510099 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-23 [patent_title] => 'Mutagenesis testing using transgenic non-human animals carrying test DNA sequences' [patent_app_type] => 1 [patent_app_number] => 8/125618 [patent_app_country] => US [patent_app_date] => 1993-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 22518 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/510/05510099.pdf [firstpage_image] =>[orig_patent_app_number] => 125618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3522524 [patent_doc_number] => 05530178 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-25 [patent_title] => 'Mutant mouse lacking CD8 surface marker' [patent_app_type] => 1 [patent_app_number] => 8/097930 [patent_app_country] => US [patent_app_date] => 1993-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 26 [patent_no_of_words] => 5327 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/530/05530178.pdf [firstpage_image] =>[orig_patent_app_number] => 097930 [rel_patent_id] =>[rel_patent_doc_number] =>)